Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;35(3):e70042.
doi: 10.1002/rmv.70042.

Mechanisms of Immune Evasion of West Nile Virus

Abdullah Alghamdi  1 , Mohammed Alissa  1 , Mohammed A Alshehri  1
Affiliations
Review

Mechanisms of Immune Evasion of West Nile Virus

Abdullah Alghamdi et al. Rev Med Virol. 2025 May.

Abstract

West Nile virus (WNV), a globally distributed flavivirus, poses a significant public health threat, causing West Nile fever and potentially severe neuroinvasive disease in humans. The absence of specific antiviral treatments and licenced human vaccines underscores the importance of understanding WNV pathogenesis, particularly the mechanisms by which it evades host immune responses. This review comprehensively analyzes the multifaceted immune evasion strategies employed by WNV, encompassing the suppression of interferon (IFN) production and signalling through targeting of STAT proteins, IRF3, and RNA sensors, the modulation of antigen presentation via downregulation of MHC molecules and impairment of proteasome function, and the manipulation of cytokine and chemokine responses to dysregulate inflammation and promote viral persistence. Furthermore, WNV exploits the blood-brain barrier (BBB) to gain access to the central nervous system (CNS), both by disrupting the barrier integrity and utilising "Trojan horse" mechanisms. The potential for antibody-dependent enhancement (ADE) further complicates the host-virus interaction. Understanding these immune evasion mechanisms is crucial for deciphering WNV pathogenesis and informing the development of effective vaccines and targeted immunotherapies aimed at preventing and treating WNV-related diseases. Future research should focus on translating this knowledge into tangible clinical benefits for at-risk populations, particularly regarding strategies to induce broadly neutralising antibody responses and robust T-cell immunity while mitigating the risk of ADE.

Keywords: West Nile Virus; antigen presentation; immune evasion; interferon; neuroinvasion.

PubMed Disclaimer

References

    1. M. S. Contigiani, L. A. Diaz, and L. Spinsanti, Flavivirus. Arthropod Borne Diseases, (2017), 73–88.
    1. T. J. Gray and C. E. Webb, “A Review of the Epidemiological and Clinical Aspects of West Nile Virus,” International Journal of General Medicine (April 2014): 193–203, https://doi.org/10.2147/ijgm.s59902.
    1. H. Singh, J. Koury, and M. Kaul, “Innate Immune Sensing of Viruses and its Consequences for the Central Nervous System,” Viruses 13, no. 2 (January2021): 170, https://doi.org/10.3390/v13020170.
    1. M. F. Martin and S. Nisole, “West Nile Virus Restriction in Mosquito and Human Cells: A Virus under Confinement,” Vaccines 8, no. 2 (May 2020): 256, https://doi.org/10.3390/vaccines8020256.
    1. J. T. O’Neal, A. A. Upadhyay, A. Wolabaugh, N. B. Patel, S. E. Bosinger, and M. S. Suthar, “West Nile Virus‐Inclusive Single‐Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response Within Single Cells,” Journal of Virology 93, no. 6 (March 2019): 10–128, https://doi.org/10.1128/jvi.01778‐18.